Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

BACKGROUND: Steroid receptor coactivators (SRCs) may modulate estrogen receptor (ER) activity and the response to endocrine treatment in breast cancer, in part through interaction with growth factor receptor signaling pathways. In the present study the effects of tamoxifen treatment on the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moi, Line L Haugan, Flågeng, Marianne Hauglid, Gjerde, Jennifer, Madsen, Andre, Røst, Therese Halvorsen, Gudbrandsen, Oddrun Anita, Lien, Ernst A, Mellgren, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420308/
https://www.ncbi.nlm.nih.gov/pubmed/22703232
http://dx.doi.org/10.1186/1471-2407-12-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420308/
https://www.ncbi.nlm.nih.gov/pubmed/22703232
http://dx.doi.org/10.1186/1471-2407-12-247

Ejemplares similares